Combretastatin: Interim Phase Ib data

Interim results from a dose-escalation, U.K. Phase Ib trial in 8 patients

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE